Annual Total Assets
$220.55 M
+$58.91 M+36.44%
December 1, 2023
Summary
- As of February 7, 2025, ORMP annual total assets is $220.55 million, with the most recent change of +$58.91 million (+36.44%) on December 1, 2023.
- ORMP annual total assets is now at all-time high.
Performance
ORMP Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$165.08 M
-$19.14 M-10.39%
September 1, 2024
Summary
- As of February 7, 2025, ORMP quarterly total assets is $165.08 million, with the most recent change of -$19.14 million (-10.39%) on September 1, 2024.
- Over the past year, ORMP quarterly total assets has dropped by -$55.47 million (-25.15%).
- ORMP quarterly total assets is now -28.50% below its all-time high of $230.89 million, reached on September 30, 2023.
Performance
ORMP Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
ORMP Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.4% | -25.1% |
| 3 y3 years | - | +1.7% |
| 5 y5 years | +536.3% | +376.3% |
ORMP Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.4% | -28.5% | +5.6% |
| 5 y | 5-year | at high | +536.3% | -28.5% | +452.5% |
| alltime | all time | at high | >+9999.0% | -28.5% | -100.0% |
Oramed Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $165.08 M(-10.4%) |
| Jun 2024 | - | $184.22 M(-9.5%) |
| Mar 2024 | - | $203.65 M(-7.7%) |
| Dec 2023 | $220.55 M(+36.4%) | $220.55 M(-4.5%) |
| Sep 2023 | - | $230.89 M(+47.7%) |
| Jun 2023 | - | $156.31 M(-2.2%) |
| Mar 2023 | - | $159.78 M(-1.2%) |
| Dec 2022 | $161.64 M(-9.1%) | $161.64 M(-1.7%) |
| Sep 2022 | - | $164.44 M(+1.3%) |
| Jun 2022 | - | $162.29 M(-5.8%) |
| Mar 2022 | - | $172.22 M(-5.6%) |
| Dec 2021 | $177.82 M(+38.9%) | - |
| Nov 2021 | - | $182.45 M(+42.5%) |
| Aug 2021 | $128.00 M(+186.8%) | $128.00 M(+59.0%) |
| May 2021 | - | $80.49 M(+30.5%) |
| Feb 2021 | - | $61.66 M(+50.5%) |
| Nov 2020 | - | $40.97 M(-8.2%) |
| Aug 2020 | $44.63 M(+28.8%) | $44.63 M(-3.3%) |
| May 2020 | - | $46.16 M(+54.5%) |
| Feb 2020 | - | $29.88 M(-4.0%) |
| Nov 2019 | - | $31.14 M(-10.2%) |
| Aug 2019 | $34.66 M(-26.9%) | $34.66 M(-7.4%) |
| May 2019 | - | $37.43 M(-10.5%) |
| Feb 2019 | - | $41.81 M(-4.1%) |
| Nov 2018 | - | $43.59 M(-8.0%) |
| Aug 2018 | $47.40 M(+22.4%) | $47.40 M(+36.8%) |
| May 2018 | - | $34.66 M(-9.4%) |
| Feb 2018 | - | $38.25 M(-7.9%) |
| Nov 2017 | - | $41.54 M(+7.3%) |
| Aug 2017 | $38.71 M(-9.6%) | $38.71 M(-2.7%) |
| May 2017 | - | $39.79 M(-4.9%) |
| Feb 2017 | - | $41.84 M(-6.9%) |
| Nov 2016 | - | $44.93 M(+4.9%) |
| Aug 2016 | $42.83 M(+62.5%) | $42.83 M(+18.0%) |
| May 2016 | - | $36.30 M(-5.4%) |
| Feb 2016 | - | $38.37 M(+60.7%) |
| Nov 2015 | - | $23.88 M(-9.4%) |
| Aug 2015 | $26.35 M | $26.35 M(+19.1%) |
| May 2015 | - | $22.13 M(-3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2015 | - | $22.98 M(-6.4%) |
| Nov 2014 | - | $24.56 M(+12.7%) |
| Aug 2014 | $21.80 M(+151.8%) | $21.80 M(-3.1%) |
| May 2014 | - | $22.50 M(-5.1%) |
| Feb 2014 | - | $23.71 M(+196.2%) |
| Nov 2013 | - | $8.01 M(-7.6%) |
| Aug 2013 | $8.66 M(+63.6%) | $8.66 M(+78.7%) |
| May 2013 | - | $4.85 M(-18.6%) |
| Feb 2013 | - | $5.96 M(-12.7%) |
| Nov 2012 | - | $6.82 M(+28.9%) |
| Aug 2012 | $5.29 M(+22.4%) | $5.29 M(+114.0%) |
| May 2012 | - | $2.47 M(-21.3%) |
| Feb 2012 | - | $3.14 M(-19.5%) |
| Nov 2011 | - | $3.90 M(-9.8%) |
| Aug 2011 | $4.33 M(+198.2%) | $4.33 M(-12.8%) |
| May 2011 | - | $4.96 M(+27.5%) |
| Feb 2011 | - | $3.89 M(+186.5%) |
| Nov 2010 | - | $1.36 M(-6.4%) |
| Aug 2010 | $1.45 M(-55.5%) | $1.45 M(-31.4%) |
| May 2010 | - | $2.12 M(-16.3%) |
| Feb 2010 | - | $2.53 M(-14.6%) |
| Nov 2009 | - | $2.96 M(-9.2%) |
| Aug 2009 | $3.26 M(-40.8%) | $3.26 M(-2.5%) |
| May 2009 | - | $3.35 M(-9.9%) |
| Feb 2009 | - | $3.71 M(-14.1%) |
| Nov 2008 | - | $4.32 M(-21.5%) |
| Aug 2008 | $5.51 M(+184.3%) | $5.51 M(+94.9%) |
| May 2008 | - | $2.83 M(+114.2%) |
| Feb 2008 | - | $1.32 M(-15.8%) |
| Nov 2007 | - | $1.57 M(-19.2%) |
| Aug 2007 | $1.94 M(+999.3%) | $1.94 M(+101.1%) |
| May 2007 | - | $963.40 K(+622.2%) |
| Feb 2007 | - | $133.40 K(+84.5%) |
| Nov 2006 | - | $72.30 K(-59.0%) |
| Aug 2006 | $176.20 K(>+9900.0%) | $176.20 K(-7.9%) |
| May 2006 | - | $191.40 K(>+9900.0%) |
| Feb 2006 | - | $0.00(0.0%) |
| Nov 2005 | - | $0.00 |
| Aug 2005 | $1300.00 | - |
FAQ
- What is Oramed Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals annual total assets year-on-year change?
- What is Oramed Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly total assets year-on-year change?
What is Oramed Pharmaceuticals annual total assets?
The current annual total assets of ORMP is $220.55 M
What is the all time high annual total assets for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual total assets is $220.55 M
What is Oramed Pharmaceuticals annual total assets year-on-year change?
Over the past year, ORMP annual total assets has changed by +$58.91 M (+36.44%)
What is Oramed Pharmaceuticals quarterly total assets?
The current quarterly total assets of ORMP is $165.08 M
What is the all time high quarterly total assets for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly total assets is $230.89 M
What is Oramed Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, ORMP quarterly total assets has changed by -$55.47 M (-25.15%)